Skip Navigation and Go To Content
News from The University of Texas Health Science Center at Houston

Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)

Navigation and Search

Health


FDA approves UTHealth Houston expansion of unique in utero spina bifida repair study using an umbilical cord patch

FDA approves UTHealth Houston expansion of unique in utero spina bifida repair study using an umbilical cord patch

July 12, 2022

Three families in three different states all share one thing in common – their children were diagnosed with spina bifida in utero.

Through their journey to find help, the families were referred to Ramesha Papanna, MD, a maternal-fetal surgeon with McGovern Medical School at UTHealth Houston and The Fetal Center at Children's Memorial Hermann Hospital, where they enrolled in a one-of-a-kind fetoscopic spina bifida study using cryopreserved umbilical cord.









COVID-19 antibodies can last up to 500 days after infection

Photo of woman getting her blood drawn. (Photo by Getty Images)

May 31, 2022

Adults infected with COVID-19 develop circulating antibodies that last for nearly 500 days, according to a new study led by researchers at UTHealth School of Public Health.

The findings were published in The Journal of Infectious Diseases.



Previous Page Page 2 of 36

More headlines »

Search UTHealth News

Use the form below to perform a new search.

Give to UTHealth